Embla Medical hf. (CPH:EMBLA)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Prosthetics & Neuro Orthotics	513.41M	451.31M	394.84M	346.52M	452.77M
Prosthetics & Neuro Orthotics Growth	13.76%	14.30%	13.94%	-23.47%	21.69%
Bracing and Supports (Incl.Compression Therapy (Phlebology))	148.38M	148.39M	146.50M	143.12M	265.90M
Bracing and Supports (Incl.Compression Therapy (Phlebology)) Growth	-0.00%	1.29%	2.36%	-46.17%	3.28%
Internal Product Sales	-39.04M	-38.52M	-35.75M	-31.08M	-
Patient Care	305.93M	293.71M	280.10M	260.09M	-
Patient Care Growth	4.16%	4.86%	7.69%	-	-
Total	928.69M	854.89M	785.69M	718.65M	718.67M
Total Growth	8.63%	8.81%	9.33%	-0.00%	14.16%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe Middle-East and Africa (EMEA)	1.07B	904.42M	806.60M	760.84M	733.49M
Europe Middle-East and Africa (EMEA) Growth	18.13%	12.13%	6.01%	3.73%	16.93%
Americas	635.09M	553.03M	518.37M	454.26M	439.42M
Americas Growth	14.84%	6.69%	14.11%	3.38%	10.39%
Asia-Pacific (APAC)	78.06M	72.08M	69.98M	74.96M	74.24M
Asia-Pacific (APAC) Growth	8.30%	3.00%	-6.64%	0.96%	15.84%
Eliminations	-852.89M	-674.64M	-609.26M	-571.41M	-528.49M
Total	928.69M	854.89M	785.68M	718.65M	718.67M
Total Growth	8.63%	8.81%	9.33%	-0.00%	14.16%

Source: S&P Global Market Intelligence.